Fennec Provides Business Update And Reports Third Quarter 2017 Results
Nov 13, 2017 11:00 am UTC| Business
During the third quarter, the Company announced positive results from its Phase 3 SIOPEL 6 Study Study met primary endpoint (p=0.0033) indicating a significant reduction in cisplatin induced hearing loss without any...
Nov 13, 2017 11:00 am UTC| Business
MAHWAH, N.J., Nov. 13, 2017 -- Radware® (NASDAQ:RDWR), a leading provider of cyber security and application delivery solutions, announced that its Attack Mitigation Solution (AMS) was selected by a major global carrier...
Nov 13, 2017 11:00 am UTC| Business
Solves CSP challenges of meeting enterprise SLAs with automated service provisioning across multiple service provider networksIndustry first solution offers dynamic intercarrier traffic management in the cloud leveraging...
Nov 13, 2017 11:00 am UTC| Business
ST. LOUIS, Nov. 13, 2017 -- Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today announced Gartner has positioned Amdocs as a Leader in its 2017 Magic Quadrant...
2nd Watch Once Again Named to Deloitte’s 2017 Technology Fast 500™
Nov 13, 2017 11:00 am UTC| Business
SEATTLE, Nov. 13, 2017 -- 2nd Watch announces it has once again been named to Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech...
Nov 13, 2017 10:54 am UTC| Business
VALLEY COTTAGE, New York, Nov. 13, 2017 -- Automatic tire inflation system is made up of a technology that is installed in the tires to manage the air pressure in each tire. It controls and guides the air...
Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation
Nov 13, 2017 10:30 am UTC| Business
PLYMOUTH, Minn., Nov. 13, 2017 -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that Anthem, Inc. now covers balloon sinus...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update